MOTTA, CATERINA
MOTTA, CATERINA
Dipartimento di Medicina dei sistemi
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation
2012-05-10 Rossi, S; Motta, C; Studer, V; Monteleone, F; De Chiara, V; Buttari, F; Barbieri, F; Bernardi, G; Battistini, L; Cutter, G; Stüve, O; Salvetti, M; Centonze, D
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis
2013-12-31 Rossi, S; Bozzali, M; Bari, M; Mori, F; Studer, V; Motta, C; Buttari, F; Cercignani, M; Gravina, P; Mastrangelo, N; Castelli, M; Mancino, R; Nucci, C; Sottile, F; Bernardini, S; Maccarrone, M; Centonze, D
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias
2021-06-01 Bonomi, Cg; De Lucia, V; Mascolo A. P. b, Am; Motta, C; Scaricamazza, E; Sallustio, F; Mercuri, Nb; Koch, G; Martorana, A
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis
2011-08-01 Rossi, S; Furlan, R; Chiara, V; Muzio, L; Musella, A; Motta, C; Studer, V; Cavasinni, F; Bernardi, G; Martino, G; Cravatt, B; Lutz, B; Maccarrone, M; Centonze, D
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis
2014-02-18 Rossi, S; Studer, V; Motta, C; Germani, G; Macchiarulo, G; Buttari, F; Mancino, R; Castelli, M; De Chiara, V; Weiss, S; Martino, G; Furlan, R; Centonze, D
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis
2013-11-15 Musella, A; Mandolesi, G; Gentile, A; Rossi, S; Studer, V; Motta, C; Sepman, H; Fresegna, D; Haji, N; Paolillo, A; Matarese, G; Centonze, D
Clinical and histological study of a xenogenic bone substitute used as a filler in postextractive alveolus
2005-01-01 Arcuri, C; Cecchetti, F; Germano, F; Motta, A; Santacroce, C
Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis
2011-02-01 Mori, F; Rossi, S; Sancesario, G; Codecà, C; Mataluni, G; Monteleone, F; Buttari, F; Kusayanagi, H; Castelli, M; Motta, C; Studer, V; Bernardi, G; Koch, G; Bernardini, S; Centonze, D
Cognitive reserve and Alzheimer's biological continuum: clues for prediction and prevention of dementia
2021-01-01 Martorana, A; Assogna, M; DE Lucia, V; Motta, C; Bonomi, Cg; Bernocchi, F; DI Donna, Mg; Koch, G
CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease
2017-01-01 Koch, G; Di Lorenzo, F; Loizzo, S; Motta, C; Travaglione, S; Baiula, M; Rimondini, R; Ponzo, V; Bonni, S; Toniolo, S; Sallustio, F; Bozzali, M; Caltagirone, C; Campana, G; Martorana, A
CT angiography ASPECTS predicts outcome much better than noncontrast CT in patients with stroke treated endovascularly
2017-01-01 Sallustio, F; Motta, C; Pizzuto, S; Diomedi, M; Rizzato, B; Panella, M; Alemseged, F; Stefanini, M; Fabiano, S; Gandini, R; Floris, R; Stanzione, P; Koch, G
CT angiography-based collateral flow and time to reperfusion are strong predictors of outcome in endovascular treatment of patients with stroke
2016-09-23 Sallustio, F; Motta, C; Pizzuto, S; Diomedi, M; Giordano, A; D'Agostino, V; Samà, D; Mangiafico, S; Saia, V; Legramante, Jm; Konda, D; Pampana, E; Floris, R; Stanzione, P; Gandini, R; Koch, G
Decreased Frontal Gamma Activity in Alzheimer Disease Patients
2022-09-01 Casula, E; Pellicciari, M; Bonnì, S; Borghi, I; Maiella, M; Assogna, M; Minei, M; Motta, C; D'Acunto, A; Porrazzini, F; Pezzopane, V; Mencarelli, L; Roncaioli, A; Rocchi, L; Spampinato, D; Caltagirone, C; Santarnecchi, E; Martorana, A; Koch, G
Diabetes Mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with APOE4 genotype
2021-07-01 Motta, C; Assogna, M; Bonomi, C; Mascolo, A; De Lucia, V; Semprini, R; Mercuri, N; Koch, G; Martorana, A
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
2023-08-30 Motta, C; Di Donna, Mg; Bonomi, Cg; Assogna, M; Chiaravalloti, A; Mercuri, Nb; Koch, G; Martorana, A
Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis
2016-02-10 Motta, C; Palermo, E; Studer, V; Germanotta, M; Germani, G; Centonze, D; Cappa, P; Rossi, S; Rossi, S
Disability and its progression can be objectively measured in multiple sclerosis
2015-04-01 Rossi, S; Palermo, G; Motta, C; Studer, V; Germanotta, M; Cappa, P; Centonze, D
Effect of Glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab
2012-06-28 Rossi, S; Motta, C; Studer, V; De Chiara, V; Barbieri, F; Monteleone, F; Fornasiero, A; Coarelli, G; Bernardi, G; Cutter, G; Stüve, O; Salvetti, M; Centonze, D
Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial
2020-07-15 Koch, G; Motta, C; Bonnì, S; Pellicciari M., C; Picazio, S; Casula, Ep; Maiella, M; Di, L; F, P; V., F; C., S; E, C; C, ; Martorana, A
Effects of cerebellar theta burst stimulation on contralateral motor cortex excitability in patients with Alzheimer’s disease
2020-01-01 Di Lorenzo, F; Bonnì, S; Picazio, S; Motta, C; Caltagirone, C; Martorana, A; Koch, G
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 10-mag-2012 | A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation | Rossi, S; Motta, C; Studer, V; Monteleone, F; De Chiara, V; Buttari, F; Barbieri, F; Bernardi, G; Battistini, L; Cutter, G; Stüve, O; Salvetti, M; Centonze, D | Articolo su rivista | |
| 31-dic-2013 | Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis | Rossi, S; Bozzali, M; Bari, M; Mori, F; Studer, V; Motta, C; Buttari, F; Cercignani, M; Gravina, P; Mastrangelo, N; Castelli, M; Mancino, R; Nucci, C; Sottile, F; Bernardini, S; Maccarrone, M; Centonze, D | Articolo su rivista | |
| 1-giu-2021 | Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias | Bonomi, Cg; De Lucia, V; Mascolo A. P. b, Am; Motta, C; Scaricamazza, E; Sallustio, F; Mercuri, Nb; Koch, G; Martorana, A | Articolo su rivista | |
| 1-ago-2011 | Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis | Rossi, S; Furlan, R; Chiara, V; Muzio, L; Musella, A; Motta, C; Studer, V; Cavasinni, F; Bernardi, G; Martino, G; Cravatt, B; Lutz, B; Maccarrone, M; Centonze, D | Articolo su rivista | |
| 18-feb-2014 | Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis | Rossi, S; Studer, V; Motta, C; Germani, G; Macchiarulo, G; Buttari, F; Mancino, R; Castelli, M; De Chiara, V; Weiss, S; Martino, G; Furlan, R; Centonze, D | Articolo su rivista | |
| 15-nov-2013 | Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis | Musella, A; Mandolesi, G; Gentile, A; Rossi, S; Studer, V; Motta, C; Sepman, H; Fresegna, D; Haji, N; Paolillo, A; Matarese, G; Centonze, D | Articolo su rivista | |
| 1-gen-2005 | Clinical and histological study of a xenogenic bone substitute used as a filler in postextractive alveolus | Arcuri, C; Cecchetti, F; Germano, F; Motta, A; Santacroce, C | Articolo su rivista | |
| 1-feb-2011 | Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis | Mori, F; Rossi, S; Sancesario, G; Codecà, C; Mataluni, G; Monteleone, F; Buttari, F; Kusayanagi, H; Castelli, M; Motta, C; Studer, V; Bernardi, G; Koch, G; Bernardini, S; Centonze, D | Articolo su rivista | |
| 1-gen-2021 | Cognitive reserve and Alzheimer's biological continuum: clues for prediction and prevention of dementia | Martorana, A; Assogna, M; DE Lucia, V; Motta, C; Bonomi, Cg; Bernocchi, F; DI Donna, Mg; Koch, G | Articolo su rivista | |
| 1-gen-2017 | CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease | Koch, G; Di Lorenzo, F; Loizzo, S; Motta, C; Travaglione, S; Baiula, M; Rimondini, R; Ponzo, V; Bonni, S; Toniolo, S; Sallustio, F; Bozzali, M; Caltagirone, C; Campana, G; Martorana, A | Articolo su rivista | |
| 1-gen-2017 | CT angiography ASPECTS predicts outcome much better than noncontrast CT in patients with stroke treated endovascularly | Sallustio, F; Motta, C; Pizzuto, S; Diomedi, M; Rizzato, B; Panella, M; Alemseged, F; Stefanini, M; Fabiano, S; Gandini, R; Floris, R; Stanzione, P; Koch, G | Articolo su rivista | |
| 23-set-2016 | CT angiography-based collateral flow and time to reperfusion are strong predictors of outcome in endovascular treatment of patients with stroke | Sallustio, F; Motta, C; Pizzuto, S; Diomedi, M; Giordano, A; D'Agostino, V; Samà, D; Mangiafico, S; Saia, V; Legramante, Jm; Konda, D; Pampana, E; Floris, R; Stanzione, P; Gandini, R; Koch, G | Articolo su rivista | |
| 1-set-2022 | Decreased Frontal Gamma Activity in Alzheimer Disease Patients | Casula, E; Pellicciari, M; Bonnì, S; Borghi, I; Maiella, M; Assogna, M; Minei, M; Motta, C; D'Acunto, A; Porrazzini, F; Pezzopane, V; Mencarelli, L; Roncaioli, A; Rocchi, L; Spampinato, D; Caltagirone, C; Santarnecchi, E; Martorana, A; Koch, G | Articolo su rivista | |
| 1-lug-2021 | Diabetes Mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with APOE4 genotype | Motta, C; Assogna, M; Bonomi, C; Mascolo, A; De Lucia, V; Semprini, R; Mercuri, N; Koch, G; Martorana, A | Articolo su rivista | |
| 30-ago-2023 | Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study | Motta, C; Di Donna, Mg; Bonomi, Cg; Assogna, M; Chiaravalloti, A; Mercuri, Nb; Koch, G; Martorana, A | Articolo su rivista | |
| 10-feb-2016 | Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis | Motta, C; Palermo, E; Studer, V; Germanotta, M; Germani, G; Centonze, D; Cappa, P; Rossi, S; Rossi, S | Articolo su rivista | |
| 1-apr-2015 | Disability and its progression can be objectively measured in multiple sclerosis | Rossi, S; Palermo, G; Motta, C; Studer, V; Germanotta, M; Cappa, P; Centonze, D | Articolo su rivista | |
| 28-giu-2012 | Effect of Glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab | Rossi, S; Motta, C; Studer, V; De Chiara, V; Barbieri, F; Monteleone, F; Fornasiero, A; Coarelli, G; Bernardi, G; Cutter, G; Stüve, O; Salvetti, M; Centonze, D | Articolo su rivista | |
| 15-lug-2020 | Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial | Koch, G; Motta, C; Bonnì, S; Pellicciari M., C; Picazio, S; Casula, Ep; Maiella, M; Di, L; F, P; V., F; C., S; E, C; C, ; Martorana, A | Articolo su rivista | |
| 1-gen-2020 | Effects of cerebellar theta burst stimulation on contralateral motor cortex excitability in patients with Alzheimer’s disease | Di Lorenzo, F; Bonnì, S; Picazio, S; Motta, C; Caltagirone, C; Martorana, A; Koch, G | Articolo su rivista |